Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2022-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
PCVX
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $800,000 | $14,458,937 |
| 2024 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $700,000 | $39,639,512 |
| 2023 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $640,000 | $12,135,684 |
| 2022 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $600,666 | $13,661,941 |
| 2021 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $574,800 | $5,291,474 |
| 2020 | Vaxcyte, Inc. (PCVX) | Chief Executive Officer | $481,042 | $3,374,620 |
Earnings-call appearances and filed executive appointments or departures, newest first.
